Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
Phase of Trial: Phase III
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Insulin aspart (Primary) ; Insulin degludec
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms onset7
- Sponsors Novo Nordisk
- 30 Aug 2017 Planned End Date changed from 9 Mar 2018 to 5 Mar 2018.
- 25 Aug 2017 Planned primary completion date changed from 9 Mar 2018 to 4 Feb 2018.
- 10 Jun 2017 Biomarkers information updated